OSTX · OS Therapies Inc
United States · RS rating 18 · As of 2026-11-03
| Price | 1.16 USD |
|---|---|
| 1-day change | +0.9% |
| RS rating (overall / 1M / 3M / 12M) | 18 / 14 / 23 / 27 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 21 / 3 / 18 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +25.9% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +48.2% |
| Market cap (USD) | $63.2M |